Adult immunization with 13-valent pneumococcal vaccine in Campania region, South Italy

References

• Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 2012; 67:71 - 9; http://dx.doi.org/10.1136/thx.2009.129502; PMID: 20729232
   PubMed Web of Science ®Google Scholar
• Health Protection Agency. Centre for Infections, London, UK. Invasive Pneumococcal Disease (IPD) in England & Wales after 7-valent conjugate vaccine (PCV7); potential impact of 10 and 13-valent vaccines. Available at http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1245581527892.
   Google Scholar
• Weycker D, Strutton D, Edelsberg J, Sato R, Jackson LA. Clinical and economic burden of pneumococcal disease in older US adults. Vaccine 2010; 28:4955 - 60; http://dx.doi.org/10.1016/j.vaccine.2010.05.030; PMID: 20576535
   PubMed Web of Science ®Google Scholar
• Cadeddu C, De Waure C, Gualano MR, Di Nardo F, Ricciardi W. 23-valent pneumococcal polysaccharide vaccine (PPV23) for the prevention of invasive pneumococcal diseases (IPDs) in the elderly: is it really effective?. J Prev Med Hyg 2012; 53:101 - 3; PMID: 23240169
   PubMedGoogle Scholar
• Hausdorff WP, Bryant J, Paradiso PR, Siber GR. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 2000; 30:100 - 21; http://dx.doi.org/10.1086/313608; PMID: 10619740
   PubMed Web of Science ®Google Scholar
• Giorgi-Rossi P, Merito M, Borgia P. Cost-effectiveness of introducing the conjugated pneumococcal vaccine to routine free immunizations for infants in Lazio, Italy. Health Policy 2009; 89:225 - 38; http://dx.doi.org/10.1016/j.healthpol.2008.05.016; PMID: 18639952
   PubMed Web of Science ®Google Scholar
• French N. Use of pneumococcal polysaccharide vaccines: no simple answers. J Infect 2003; 46:78 - 86; http://dx.doi.org/10.1053/jinf.2002.1113; PMID: 12634068
   PubMed Web of Science ®Google Scholar
• Obert J, Burgel PR. Pneumococcal infections: association with asthma and COPD. Med Mal Infect 2012; 42:188 - 92; PMID: 22444165
   PubMed Web of Science ®Google Scholar
• Smith SA, Poland GA. Use of influenza and pneumococcal vaccines in people with diabetes. Diabetes Care 2000; 23:95 - 108; http://dx.doi.org/10.2337/diacare.23.1.95; PMID: 10857977
   PubMed Web of Science ®Google Scholar
• Nelson JC, Jackson M, Yu O, Whitney CG, Bounds L, Bittner R, Zavitkovsky A, Jackson LA. Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults. Vaccine 2008; 26:4947 - 54; http://dx.doi.org/10.1016/j.vaccine.2008.07.016; PMID: 18662735
   PubMed Web of Science ®Google Scholar
• Huang SS, Johnson KM, Ray GT, Wroe P, Lieu TA, Moore MR, Zell ER, Linder JA, Grijalva CG, Metlay JP, et al. Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine 2011; 29:3398 - 412; http://dx.doi.org/10.1016/j.vaccine.2011.02.088; PMID: 21397721
   PubMed Web of Science ®Google Scholar
• Icardi G, Sticchi L, Bagnasco A, Iudici R, Durando P. Pneumococcal vaccination in adults: rationale, state of the art and perspectives. J Prev Med Hyg 2012; 53:78 - 84; PMID: 23240164
   PubMedGoogle Scholar
• della Salute M. Piano Nazionale Prevenzione Vaccinale 2012-14. Gazzetta Ufficiale n. 47 (12 March 2012). Available at: http://www.salute.gov.it/imgs/C_17_pubblicazioni_1721_allegato.pdf
   Google Scholar
• Ministero della Salute. Circolare n. 11 del 19 Novembre 2001. Vaccinazione antipneumococcica in età pediatrica. Available at: http://www.salute.gov.it/imgs/C_17_normativa_78_allegato.pdf
   Google Scholar
• Ministero della Salute. Circolare del 29 Luglio 2010. Circolare Prevenzione e controllo dell’influenza: raccomandazioni per la stagione 2010-2012. Available at: http://www.trovanorme.salute.gov.it/renderNormsanPdf?anno=0&codLeg=34861&parte=1%20&serie=
   Google Scholar
• Vila-Corcoles A, Ochoa-Gondar O, Guzmán JA, Rodriguez-Blanco T, Salsench E, Fuentes CM, EPIVAC Study Group. Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older. BMC Infect Dis 2010; 10:73; http://dx.doi.org/10.1186/1471-2334-10-73; PMID: 20298596
   PubMed Web of Science ®Google Scholar
• Vila-Córcoles A, Ochoa-Gondar O, Hospital I, Ansa X, Vilanova A, Rodríguez T, Llor C, EVAN Study Group. Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study. Clin Infect Dis 2006; 43:860 - 8; http://dx.doi.org/10.1086/507340; PMID: 16941367
   PubMed Web of Science ®Google Scholar
• Moberley SA, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008; CD000422; PMID: 18253977
   PubMedGoogle Scholar
• Jackson LA, Neuzil KM, Nahm MH, Whitney CG, Yu O, Nelson JC, Starkovich PT, Dunstan M, Carste B, Shay DK, et al. Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide-protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. Vaccine 2007; 25:4029 - 37; http://dx.doi.org/10.1016/j.vaccine.2007.02.062; PMID: 17391816
   PubMed Web of Science ®Google Scholar
• The Committee for Medicinal Products for Human Use. European Medicines Agency. Prevenar 13. Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed). Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion/human/001104/WC500112838.pdf.
   Google Scholar
• de Roux A, Schmöle-Thoma B, Siber GR, Hackell JG, Kuhnke A, Ahlers N, Baker SA, Razmpour A, Emini EA, Fernsten PD, et al. Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. Clin Infect Dis 2008; 46:1015 - 23; http://dx.doi.org/10.1086/529142; PMID: 18444818
   PubMed Web of Science ®Google Scholar
• Schwarz TF, Flamaing J, Rümke HC, Penzes J, Juergens C, Wenz A, Jayawardene D, Giardina P, Emini EA, Gruber WC, et al. A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years. Vaccine 2011; 29:5195 - 202; http://dx.doi.org/10.1016/j.vaccine.2011.05.031; PMID: 21619909
   PubMed Web of Science ®Google Scholar
• Viegi G, Maio S, Pistelli F, Baldacci S, Carrozzi L. Epidemiology of chronic obstructive pulmonary disease: health effects of air pollution. Respirology 2006; 11:523 - 32; http://dx.doi.org/10.1111/j.1440-1843.2006.00886.x; PMID: 16916323
   PubMed Web of Science ®Google Scholar
• Boccalini S, Bechini A, Levi M, Tiscione E, Gasparini R, Bonanni P. Cost-effectiveness of new adult pneumococcal vaccination strategies in Italy. Hum Vaccin Immunother 2013; 9; http://dx.doi.org/10.4161/hv.23268; PMID: 23295824
   PubMed Web of Science ®Google Scholar
• Popolazione residente al 1 Gennaio 2009 per età, sesso e stato civile. Demo.istat. Demografia in cifre. Istituto Nazionale di Statistica. Available at: http://demo.istat.it
   Google Scholar
• Agenzia Regionale Sanitaria. Dati relativi alle polmoniti in Campania anni 2010-2011v, codici 481-486. Available at: http://www.arsan.campania.it/
   Google Scholar
• Bewick T, Sheppard C, Greenwood S, Slack M, Trotter C, George R, Lim WS. Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia. Thorax 2012; 67:540 - 5; http://dx.doi.org/10.1136/thoraxjnl-2011-201092; PMID: 22374921
   PubMed Web of Science ®Google Scholar
• Black SB, Shinefield HR, Ling S, Hansen J, Fireman B, Spring D, Noyes J, Lewis E, Ray P, Lee J, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J 2002; 21:810 - 5; http://dx.doi.org/10.1097/00006454-200209000-00005; PMID: 12352800
   PubMed Web of Science ®Google Scholar
• Decessi e mortalità in Campania. Istituto Nazionale di Statistica. Available at: http://demo.istat.it
   Google Scholar
• Agenzia Nazionale per i Servizi Sanitari Regionali. (Age.na.s.). Ricoveri ospedalieri, i sistemi tariffari regionali vigenti nell’anno 2009. Regione Campania. Available at: http://www.agenas.it/index.htm
   Google Scholar